Prestige Consumer Healthcare (PBH)
NYSEHealth CareMedical - PharmaceuticalsSnapshot 2026-11-04
$44.32-16.82%
Close 2026-11-05 · 1-day change
NYSEHealth CareMedical - PharmaceuticalsSnapshot 2026-11-04
QuarterlyIQ Insights · PBH
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2013 | Mar 2012 | Mar 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 1,167.1 | 1,088.7 | 1,137.8 | 1,125.4 | 1,127.7 | 1,086.8 | 943.4 | 963.0 | 975.8 | 1,041.2 | 882.1 | 806.2 | 713.5 | 597.4 | 620.1 | 441.1 |
| Total Revenues | — | — | — | — | — | — | — | — | 975.8 | 1,041.2 | 882.1 | 806.2 | 713.5 | 597.4 | 620.1 | 441.1 |
| Cost of Revenues | 554.7 | 493.1 | 503.3 | 500.9 | 502.4 | 466.2 | 395.9 | 410.8 | 420.2 | 464.7 | 381.8 | 339.0 | — | — | — | — |
| Gross Profit | 612.4 | 595.6 | 634.5 | 624.4 | 625.3 | 620.6 | 547.5 | 552.2 | 555.6 | 576.5 | 500.3 | 467.2 | 406.2 | 335.6 | 343.7 | 227.4 |
| Operating Expenses & Income | ||||||||||||||||
| Operating Income | 291.2 | 309.4 | 336.8 | 342.4 | (22.4) | 329.9 | 297.4 | 291.2 | 67.5 | 215.5 | 205.6 | 260.3 | 207.6 | 188.6 | 191.9 | 102.8 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | 1.8 | 5.2 | — | — | — | — | — | — | — | — | — | — | — | — |
| Interest & Investment Income | — | — | — | — | — | — | — | 0.3 | 0.2 | 0.4 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 |
| Asset Writedown | — | — | 12.5 | — | 370.2 | 1.1 | 2.4 | — | 229.5 | 99.9 | 0.0 | 0.0 | — | — | — | — |
| EBT, Incl. Unusual Items | — | 257.5 | 284.2 | 276.0 | (93.9) | 262.5 | 204.1 | 191.2 | (38.1) | 107.1 | 110.9 | 157.2 | 127.5 | 101.7 | 106.0 | 61.2 |
| Income Tax Expense | 57.5 | 67.2 | 69.6 | 66.7 | (11.6) | 57.1 | 39.4 | 48.9 | (2.3) | (232.5) | 41.5 | 57.3 | 49.2 | 29.1 | 40.5 | 23.9 |
| Net Income | ||||||||||||||||
| Net Income | 155.1 | 190.3 | 214.6 | 209.3 | (82.3) | 205.4 | 164.7 | 142.3 | (35.8) | 339.6 | 69.4 | 99.9 | 78.3 | 72.6 | 65.5 | 37.2 |
| Per Share | ||||||||||||||||
| Basic EPS | 3.27 | 3.93 | 4.32 | 4.21 | (1.65) | 4.09 | 3.28 | 2.81 | (0.69) | 6.40 | 1.31 | 1.89 | 1.50 | 1.41 | 1.29 | 0.74 |
| Diluted EPS | 3.26 | 3.91 | 4.29 | 4.17 | (1.65) | 4.04 | 3.25 | 2.78 | (0.69) | 6.34 | 1.30 | 1.88 | 1.49 | 1.39 | 1.27 | 0.73 |
| Revenue per Share | 24.52 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 47.5 | 48.5 | 49.7 | 49.8 | 49.9 | 50.3 | 50.2 | 50.7 | 52.1 | 53.1 | 53.0 | 52.8 | 52.2 | 51.6 | 50.6 | 50.3 |
| Diluted Weighted Avg Shares | 47.6 | 48.7 | 50.1 | 50.2 | 49.9 | 50.8 | 50.6 | 51.1 | 52.1 | 53.5 | 53.4 | 53.1 | 52.7 | 52.3 | 51.4 | 50.7 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 340.7 | 366.9 | 373.1 | 10.2 | 362.0 | 327.6 | 320.2 | 99.3 | 248.9 | 231.4 | 284.0 | 225.3 | 202.1 | 205.1 | 113.6 |
| EBIT | 291.2 | 309.4 | 336.8 | 342.4 | (22.4) | 329.9 | 297.4 | 291.2 | 67.5 | 215.5 | 205.6 | 260.3 | 207.6 | 188.6 | 191.9 | 102.8 |
| Effective Tax Rate | — | — | — | — | — | — | — | — | 5.9% | -217.1% | 37.4% | 36.4% | 38.6% | 28.6% | 38.2% | 39.2% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.